Top Institutions in Ophthalmology - Glaucoma Neuroprotection
Institutions leading in this area are recognized for their pioneering clinical trials, translational research in glaucoma neuroprotection, and expertise in retinal cell biology and mitochondrial function. Their work includes large-scale patient enrollment, safety monitoring, and guideline development for novel glaucoma therapies.
-
#1
Columbia University Irving Medical Center
New York, NY
Leads major clinical trials investigating nicotinamide as a neuroprotective agent in glaucoma, with extensive translational research linking mitochondrial function to retinal ganglion cell preservation.
-
#2
Moorfields Eye Hospital
London, N/A
One of the leading eye hospitals globally with a strong focus on glaucoma clinical trials and neuroprotective strategies, including international collaborations on nicotinamide research.
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Top-ranked ophthalmology institute with a robust glaucoma research program focusing on neuroprotection and retinal ganglion cell preservation, contributing to clinical and laboratory studies on nicotinamide.
-
#4
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Known for cutting-edge research in glaucoma pathophysiology and neuroprotection, including early-phase clinical trials and safety assessments of novel treatments like nicotinamide.
-
#5
Singapore National Eye Centre
Singapore, N/A
Leads regional clinical trials on glaucoma neuroprotection, including monitoring adverse events related to nicotinamide supplementation, contributing valuable safety data.